Prague Med. Rep. 2023, 124, 230-241

https://doi.org/10.14712/23362936.2023.18

Effect of Convalescent Plasma Therapy on Mortality and Viral Load in Severely Ill Patients with COVID-19

Jan Moravec1, Martin Müller1, Petr Turek2, Michal Moravec1, Tomáš Nejtek1, Roman Zazula1

1Department of Anesthesiology and Intensive Care, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic
2Department of Blood Transfusion, Thomayer University Hospital, Prague, Czech Republic

Received February 27, 2023
Accepted August 27, 2023

References

1. Balík, M., Bohoněk, M., Černý, V., Holub, M., Kümpel, P., Plíšek, S., Roháčová, H. (2020) Doporučený postup pro použití rekonvalescentní plazmy v léčbě dospělých pacientů s COVID-19. Česká Společnost Anesteziologie, Resuscitace a Intenzivní Medicíny ČLS JEP. Available at: https://www.csarim.cz/getmedia/975c0db9-cc03-4b15-812a-377d41713e61/08_dp_covid_stl_csarim_sil_rekonvalesc_plazma_300420_2.pdf.aspx (Accessed 12. 12. 2022)
2. Bégin, P., Callum, J., Jamula, E., Cook, R., Heddle, N. M., Tinmouth, A., Zeller, M. P., Beaudoin-Bussières, G., Amorim, L., Bazin, R., Loftsgard, K. C., Carl, R., Chassé, M., Cushing, M. M., Daneman, N., Devine, D. V., Dumaresq, J., Fergusson, D. A., Gabe, C., Glesby, M. J., Li, N., Liu, Y., McGeer, A., Robitaille, N., Sachais, B. S., Scales, D. C., Schwartz, L., Shehata, N., Turgeon, A. F., Wood, H., Zarychanski, R., Finzi, A.; CONCOR-1 Study Group; Arnold, D. M. (2021) Convalescent plasma for hospitalized patients with COVID-19: An open-label, randomized controlled trial. Nat. Med. 27, 2012–2024. <https://doi.org/10.1038/s41591-021-01488-2>
3. Behring, E. A. (1890) Untersuchungen über das Zustandekommen der Diphtherie-Immunität bei Thieren. Dtsch. Med. Wochenschr. 1890, 1145–1148.
4. Bohoněk, M., Černý, V., Holub, M., Dlouhý, P., Vašáková, M. (2021) Mezioborové stanovisko (evidenční číslo ČSARIM: 18/2021) k podávání rekonvalescentní plazmy u pacientů s COVID-19. Česká Společnost Anesteziologie, Resuscitace a Intenzivní Medicíny ČLS JEP. Available at: https://www.csarim.cz/getmedia/0d4a80ec-41de-459b-aa2c-1f6a2f1042a5/2021_PP_18_CSARIM_STL_SIL_CPFS_Rekonv_plazma_final_020321.pdf
5. Bracha, A., Tan, S. Y. (2011) Emil von Behring (1854–1917): Medicine’s first Nobel laureate. Singapore Med. J. 52, 1–2.
6. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. NIH COVID-19 Treatment Guidelines. Available at: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf
7. Dadras, O., Afsahi, A. M., Pashaei, Z., Mojdeganlou, H., Karimi, A., Habibi, P., Barzegary, A., Fakhfouri, A., Mirzapour, P., Janfaza, N., Dehghani, S., Afroughi, F., Dashti, M., Khodaei, S., Mehraeen, E., Voltarelli, F., Sabatier, J.-M., SeyedAlinaghi, S. (2022) The relationship between COVID-19 viral load and disease severity: A systematic review. Immun. Inflamm. Dis. 10, e580. <https://doi.org/10.1002/iid3.580>
8. Denkinger, C. M., Janssen, M., Schäkel, U., Gall, J., Leo, A., Stelmach, P., Weber, S. F., Krisam, J., Baumann, L., Stermann, J., Merle, U., Weigand, M. A., Nusshag, C., Bullinger, L., Schrezenmeier, J.-F., Bornhäuser, M., Alakel, N., Witzke, O., Wolf, T., Vehreschild, M. J. G. T., Schmiedel, S., Addo, M. M., Herth, F., Kreuter, M., Tepasse, P.-R., Hertenstein, B., Hänel, M., Morgner, A., Kiehl, M., Hopfer, O., Wattad, M.-A., Schimanski, C. C., Celik, C., Pohle, T., Ruhe, M., Kern, W. V., Schmitt, A., Lorenz, H.-M., Souto-Carneiro, M., Gaeddert, M., Halama, N., Meuer, S., Kräusslich, H.-G., Müller, B., Schnitzler, P., Parthé, S., Bartenschlager, R., Gronkowski, M., Klemmer, J., Schmitt, M., Dreger, P., Kriegsmann, K., Schlenk, R. F., Müller-Tidow, C. (2023) Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: A randomized clinical trial. Nat. Cancer 4, 96–107.
9. Fajnzylber, J., Regan, J., Coxen, K., Corry, H., Wong, C., Rosenthal, A., Worrall, D., Giguel, F., Piechocka-Trocha, A., Atyeo, C., Fischinger, S., Chan, A., Flaherty, K. T., Hall, K., Dougan, M., Ryan, E. T., Gillespie, E., Chishti, R., Li, Y., Jilg, N., Hanidziar, D., Baron, R. M., Baden, L., Tsibris, A. M., Armstrong, K. A., Kuritzkes, D. R., Alter, G., Walker, B. D., Yu, X., Li, J. Z. (2020) SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat. Commun. 11, 5493. <https://doi.org/10.1038/s41467-020-19057-5>
10. Luke, T. C., Kilbane, E. M., Jackson, J. L., Hoffman, S. L. (2006) Meta-analysis: Convalescent blood products for Spanish influenza pneumonia: A future H5N1 treatment? Ann. Intern. Med. 145, 599–609. <https://doi.org/10.7326/0003-4819-145-8-200610170-00139>
11. Mallano, A., Ascione, A., Flego, M. (2022) Antibody response against SARS-CoV-2 infection: Implications for diagnosis, treatment and vaccine development. Int. Rev. Immunol. 41, 393–413. <https://doi.org/10.1080/08830185.2021.1929205>
12. RECOVERY Collaborative Group (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial. Lancet 397, 1637–1645.
13. Rosas, I. O., Bräu, N., Waters, M., Go, R. C., Hunter, B. D., Bhagani, S., Skiest, D., Aziz, M. S., Cooper, N., Douglas, I. S., Savic, S., Youngstein, T., Del Sorbo, L., Cubillo Gracian, A., De La Zerda, D. J., Ustianowski, A., Bao, M., Dimonaco, S., Graham, E., Matharu, B., Spotswood, H., Tsai, L., Malhotra, A. (2021) Tocilizumab in hospitalized patients with severe Covid-19 pneumonia. N. Engl. J. Med. 384, 1503–1516. <https://doi.org/10.1056/NEJMoa2028700>
14. Turek, P. (2020) Darování plazmy po prodělané infekci koronavirem (COVID-19). Transfuzní Oddělení, Fakultní Thomayerova nemocnice. Available at: https://www.ftn.cz/upload/ftn/Kliniky/Transfuzni_odd/Dokumenty/TN_TRA_COVID-19_nabor.pdf
15. Turek, P., Dresler, J., Hamšíková, E., Gašová, Z., Dušková, D., Ibrahimová, M., Kabíčková, H., Kubíčková, P. (2020) Vyšetření anti-SARS-CoV-2 virus-neutralizačním testem a IgG Elisa testem Euroimmun. Transfuze a Hematologie Dnes 26, 27.
16. Vafadar Moradi, E., Teimouri, A., Rezaee, R., Morovatdar, N., Foroughian, M., Layegh, P., Rezvani Kakhki, B., Ahmadi Koupaei, S. R., Ghorani, V. (2021) Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality. Am. J. Emerg. Med. 40, 11–14. <https://doi.org/10.1016/j.ajem.2020.12.003>
17. Wang, X., Guo, X., Xin, Q., Pan, Y., Hu, Y., Li, J., Chu, Y., Feng, Y., Wang, Q. (2020) Neutralizing antibody responses to severe acute respiratory syndrome coronavirus 2 in coronavirus disease 2019 inpatients and convalescent patients. Clin. Infect. Dis. 71, 2688–2694. <https://doi.org/10.1093/cid/ciaa721>
18. Writing Committee for the REMAP-CAP Investigators; Estcourt, L. J., Turgeon, A. F., McQuilten, Z. K., McVerry, B. J., Al-Beidh, F., Annane, D., Arabi, Y. M., Arnold, D. M., Beane, A., Bégin, P., van Bentum-Puijk, W., Berry, L. R., Bhimani, Z., Birchall, J. E., Bonten, M. J. M., Bradbury, C. A., Brunkhorst, F. M., Buxton, M., Callum, J. L., Chassé, M., Cheng, A. C., Cove, M. E., Daly, J., Derde, L., Detry, M. A., De Jong, M., Evans, A., Fergusson, D. A., Fish, M., Fitzgerald, M., Foley, C., Goossens, H., Gordon, A. C., Gosbell, I. B., Green, C., Haniffa, R., Harvala, H., Higgins, A. M., Hills, T. E., Hoad, V. C., Horvat, C., Huang, D. T., Hudson, C. L., Ichihara, N., Laing, E., Lamikanra, A. A., Lamontagne, F., Lawler, P. R., Linstrum, K., Litton, E., Lorenzi, E., MacLennan, S., Marshall, J., McAuley, D. F., McDyer, J. F., McGlothlin, A., McGuinness, S., Miflin, G., Montgomery, S., Mouncey, P. R., Murthy, S., Nichol, A., Parke, R., Parker, J. C., Priddee, N., Purcell, D. F. J., Reyes, L. F., Richardson, P., Robitaille, N., Rowan, K. M., Rynne, J., Saito, H., Santos, M., Saunders, C. T., Serpa Neto, A., Seymour, C. W., Silversides, J. A., Tinmouth, A. A., Triulzi, D. J., Turner, A. M., van de Veerdonk, F., Walsh, T. S., Wood, E. M., Berry, S., Lewis, R. J., Menon, D. K., McArthur, C., Zarychanski, R., Angus, D. C., Webb, S. A., Roberts, D. J., Shankar-Hari, M. (2021) Effect of convalescent plasma on organ support-free days in critically ill patients with COVID-19: A randomized clinical trial. JAMA 326, 1690–1702.
19. Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D., Zhou, Y. (2021) The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduct. Target. Ther. 6, 1–20.
front cover

ISSN 1214-6994 (Print) ISSN 2336-2936 (Online)

Archive